GlassScriptPhysician profile
Oran Schachter
NPI 1063831642
$1,932.21
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,073 · 2022: $85.36 · 2023: $571 · 2024: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $569 · Travel and Lodging: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $569.47 |
| Travel and Lodging | $204.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $559.89 | 2019 | |
| Smith+Nephew, INC. | $219.24 | 2019-2023 | Grafix Pl, Grafix |
| Stryker Corporation | $204.35 | 2023 | Prostep |
| Organogenesis INC. | $139.82 | 2019-2024 | |
| Kerecis Limited | $132.46 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $90.36 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Abbvie INC. | $67.55 | 2023-2024 | |
| Kci USA, INC. | $58.84 | 2023 | Activ.A.C., V.A.C.Ulta, V.A.C.Instill |
| Polynovo North America LLC | $50.27 | 2024 | Novosorb Btm |
| Tactile Systems Technology INC | $39.47 | 2019-2022 | |
| Polarityte, INC. | $35.58 | 2019 | |
| Next Science LLC | $33.34 | 2023 | Blastx, Surgx, Xperience |
| Paratek Pharmaceuticals, INC. | $32.09 | 2022-2023 | Nuzyra |
| Bioventus LLC | $31.73 | 2019 | |
| Orthofix Medical, INC. | $31.16 | 2024 | Physio-Stim |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osiris Therapeutics INC. | $25.12 | 2019 | |
| Hartmann USA, INC. | $23.68 | 2024 | Zetuvit Plus 10x10 P10 |
| Misonix INC | $23.57 | 2019 | |
| Celularity INC. | $22.00 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $21.78 | 2019 | |
| Medela LLC | $20.93 | 2019 | |
| Abbott Laboratories | $20.76 | 2023 | Proclaim |
| Tei Medical INC. | $18.26 | 2019 | |
| Medtronic, INC. | $15.86 | 2023 | Accurian |
| Musculoskeletal Transplant Foundation INC. | $14.10 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oran Schachter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.